Endothelial Nitric Oxide Synthase Gene Polymorphisms in Giant Cell Arteritis

Arthritis and Rheumatism

Volumn 48, Issue 11, 2003, Pages 3219-3223

  Salvarani, Carlo ^a   Casali, Bruno ^a   Nicoli, Davide ^a   Farnetti, Enrico ^a   Macchioni, Pierluigi ^a   Catanoso, Maria Grazia ^a   Chen, Qingquan ^a   Bajocchi, GianLuigi ^a   Boiardi, Luigi ^a  

^a S MARIA NUOVA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; GLUTAMIC ACID; NITRIC OXIDE SYNTHASE;

ADULT; AGED; AORTA ARCH SYNDROME; ARTICLE; CLAUDICATION; CONTROLLED STUDY; DNA POLYMORPHISM; EXON; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE; GIANT CELL ARTERITIS; HUMAN; INTRON; ISCHEMIA; ITALY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VISUAL IMPAIRMENT;

AGED; ASPARTIC ACID; DNA; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTAMIC ACID; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; TEMPORAL ARTERITIS;

EID: 0242579528     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.11307     Document Type: Article

References (35)

1. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant cell arteritis. N Engl J Med 2002;347:261-71.
2. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43: 109-42.
3. Wang Y, Marsden PA. Nitric oxide synthases: biochemical and molecular regulation. Curr Opin Nephrol Hypertens 1995;4:12-22.
4. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-6.
5. Radomski MW, Palmer RM, Moncada S. Characterization of the L-arginine: nitric oxide pathway in human platelets. Br J Pharmacol 1990;101:325-8.
6. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989;83:1774-7.
7. Radomski MW, Palmer RM, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987;2:1057-8.
8. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A 1991;88:4651-5.
9. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr, et al. Nitric oxide decreases cytokine-induced endothelial activation: nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995;96:60-8.
10. Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DE. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 1996;2:41-5.
11. Ichihara S, Yamada Y, Fujimura T, Nakashima N, Yokota M. Association of a polymorphism of the endothelial constitutive nitric oxide synthase gene with myocardial infarction in the Japanese population. Am J Cardiol 1998;81:83-6.
12. Shimasaki Y, Yasue H, Yoshimura M, Nakayama M, Kugiyama K, Ogawa H, et al. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol 1998;31:1506-10.
13. Ishigami T, Tamura K, Fujita T, Kobayashi I, Hibi K, Kihara M, et al. Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension 1998;32:521-6.
14. Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, Parsons A, et al. A common variant of the endothelial nitric oxide synthase (Glu298→Asp) is a major risk factor for coronary artery disease in the UK. Circulation 1999;100:1515-20.
15. Fowkes FG, Lee AJ, Hau CM, Cooke A, Connor JM, Lowe GD. Methylene tetrahydrofolate reductase (MTHFR) and nitric oxide synthase (ecNOS) genes and risks of peripheral arterial disease and coronary heart disease: Edinburgh Artery Study. Atherosclerosis 2000;150:179-85.
16. Hooper WC, Lally C, Austin H, Benson J, Dilley A, Wenger NK, et al. The relationship between polymorphisms in the endothelial cell nitric oxide synthase gene and the platelet GPIIIa gene with myocardial infarction and venous thromboembolism in African Americans. Chest 1999;116:880-6.
17. Tesauro M, Thompson WC, Rogliani P, Qi L, Chaudhary PP, Moss J. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci U S A 2000;97:2832-5.
18. Philip I, Plantefeve G, Vuillaumier-Barrot S, Vicaut E, LeMarie C, Henrion D, et al. G894T polymorphism in the endothelial nitric oxide synthase gene is associated with an enhanced vascular responsiveness to phenylephrine. Circulation 1999;99:3096-8.
19. Tsukada T, Yokoyama K, Arai T, Takemoto F, Hara S, Yamada A, et al. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun 1998;245:190-3.
20. Veldman BA, Spiering W, Doevendans PA, Vervoort G, Kroon AA, de Leeuw PW, et al. The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. J Hypertens 2002;20:2023-7.
21. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. Nolan C, editor. Cold Spring Harbor (NY): Cold Spring Harbor Press; 1989. p. 9.17-9.
22. Uwabo J, Soma M, Nakayama T, Kanmatsuse K. Association of variable number of tandem repeats in the endothelial costitutive nitric oxide synthase gene with essential hypertension in Japanese. Am J Hypertens 1998;11:125-8.
23. Uddhammar AC. Von Willebrand factor in polymyalgia rheumatica and giant cell arteritis. Clin Exp Rheumatol 2000;18 Suppl 20:32-3.
24. Pache M, Kaiser HJ, Haufschild T, Lubeck P, Flammer J. Increased endothelin-1 plasma levels in giant cell arteritis: a report on four patients. Am J Ophthalmol 2002;133:160-2.
25. Coll-Vinent B, Vilardell C, Font C, Oristrell J, Hernandez-Rodriguez J, Yague J, et al. Circulating soluble adhesion molecules in patients with giant cell arteritis: correlation between soluble intercellular adhesion molecule-1 (sICAM-1) concentrations and disease activity. Ann Rheum Dis 1999;58:189-92.
26. Weyand CM, Goronzy JJ. Pathogenic principles in giant cell arteritis. Int J Cardiol 2000;75 Suppl 1:S9-15.
27. Kaiser M, Younge B, Bjornsson J, Goronzy JJ, Weyand CM. Formation of new vasa vasorum in vasculitis: production of angiogenic cytokines by multinucleated giant cells. Am J Pathol 1999;155:765-74.
28. Borkowski A, Younge BR, Szweda L, Mock B, Bjornsson J, Moeller K, et al. Reactive nitrogen intermediates in giant cell arteritis: selective nitration of neocapillaries. Am J Pathol 2002; 161:115-23.
29. Anderson TJ. Assessment and treatment of endothelial dysfunction in humans. J Am Coll Cardiol 1999;34:631-8.
30. Salvarani C, Boiardi L, Casali B, Olivieri I, Ciancio G, Cantini F, et al. Endothelial nitric oxide synthase gene polymorphisms in Beḩet's disease. J Rheumatol 2002;29:535-40.
31. Chambers JC, Haskard DO, Kooner JS. Vascular endothelial function and oxidative stress mechanisms in patients with Beḩet's syndrome. J Am Coll Cardiol 2001;37:517-20.
32. Nesher G, Mates M, Barkun J, Rubinow A, Sonneblick M. Low dose aspirin and prevention of stroke and visual loss in giant cell arteritis. Arthritis Rheum 2002;46 Suppl:S182.
33. Cantini F, Niccoli L, Salvarani C, Padula A, Olivieri I. Treatment of longstanding active giant cell arteritis with infliximab: report of four cases. Arthritis Rheum 2001;44:2933-5.
34. Kharbanda RK, Walton B, Allen M, Klein N, Hingorani AD, MacAllister RJ, et al. Prevention of inflammation-induced endothelial dysfunction: a novel vasculo-protective action of aspirin. Circulation 2002;105:2600-4.
35. Hurlimann D, Forster A, Noll G, Enseleit F, Chenevard R, Distler O, et al. Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 2002;106:2184-7.